What was the total repurchase activity in H1 2026?

Ecovyst repurchased 3,226,461 shares at an average price of $11.07 per share for a total cost of $35.7 million during the six months ended June 30, 2026. No shares were repurchased during Q2 2026 specifically.

How much authorization remains under the program?

As of June 30, 2026, $146.5 million remained available for repurchases out of the original $450 million authorization approved in April 2022. This means the company has utilized approximately 67.4% of its authorized amount over approximately four years.

When was the expiration date removed from the program?

The Board of Directors approved the removal of the expiration date in October 2025, making the buyback program perpetual. Previously, the program had a defined termination date, but now it may continue indefinitely subject to board discretion.

What execution mechanisms can the company use for future repurchases?

The company may conduct repurchases through negotiated transactions, open market purchases, Rule 10b-18 trading plans, Rule 10b5-1 plans, or accelerated stock repurchases. The specific mechanism used for H1 2026 repurchases was open-market purchases.

Why did the company not repurchase shares in Q2 2026?

The filing does not specify a reason for the absence of Q2 2026 repurchases. However, the company completed the $178.5 million acquisition of the Calabrian sulfur dioxide business on June 30, 2026, and increased term debt by $100 million, which may have influenced capital allocation priorities toward debt management and integration.

How does this buyback program fit into the company's overall capital strategy?

The company states it is 'focused on creating long-term stockholder value' and pursues 'synergistic acquisitions' alongside the buyback program. The perpetual authorization (as of October 2025) provides flexibility for opportunistic repurchases, though the company prioritizes maintaining adequate liquidity and debt ratios during periods of acquisition activity.

ECVT 8-K Filed 2026-08-05 Execution disclosure

Ecovyst repurchased 3.2M shares in H1 2026; $146.5M remains under $450M program

Execution update: 3.2M shares at $11.07 average price for $35.7M; board removed expiration date in October 2025.

Shares repurchased3.2M

Avg price paid$11.07

Remaining$146M

MechanismRule 10b-18 and Rule 10b5-1 tr

What the filing says

Ecovyst Inc. (NYSE: ECVT) reported that for the six months ended June 30, 2026, the company repurchased 3,226,461 shares of its common stock on the open market at an average price of $11.07 per share, for a total cost of $35.7 million. During the second quarter of 2026 specifically, the company did not repurchase any shares.

The buyback activity was conducted under a stock repurchase program authorized by the Board of Directors in April 2022 for up to $450 million of outstanding common stock. In October 2025, the Board approved the removal of the expiration date of the program, effectively making it perpetual. As of June 30, 2026, $146.5 million remained available for future repurchases under the authorization.

The company indicated that future repurchases may be conducted through negotiated transactions, open market repurchases, or other means, including through Rule 10b-18 and Rule 10b5-1 trading plans or accelerated stock repurchases. The repurchase program does not obligate the company to acquire any shares in any specific period and may be amended, suspended, or discontinued at any time at the company's discretion.

For the six months ended June 30, 2026, the Company repurchased 3,226,461 shares of its common stock on the open market at an average price of $11.07 per share, for a total cost of $35.7 million. — Ecovyst Inc. 8-K filing · View on SEC EDGAR →

What this means

Ecovyst has now exhausted $303.5 million of its $450 million buyback authorization over approximately four years since the April 2022 approval. The H1 2026 repurchase of 3.2 million shares represents a measured pace relative to the company's recent acquisition activity and capital structure changes—the company incurred $178.5 million in business combination costs in the first half of 2026, including the June 2026 Calabrian acquisition, which increased term debt by $100 million. The removal of the program's expiration date in October 2025 signals the company's intent to continue opportunistic buybacks when conditions permit, though Q2 2026 saw zero repurchases, suggesting the company prioritized capital preservation amid acquisition integration and debt management.

Frequently asked questions

What was the total repurchase activity in H1 2026?: Ecovyst repurchased 3,226,461 shares at an average price of $11.07 per share for a total cost of $35.7 million during the six months ended June 30, 2026. No shares were repurchased during Q2 2026 specifically.
How much authorization remains under the program?: As of June 30, 2026, $146.5 million remained available for repurchases out of the original $450 million authorization approved in April 2022. This means the company has utilized approximately 67.4% of its authorized amount over approximately four years.
When was the expiration date removed from the program?: The Board of Directors approved the removal of the expiration date in October 2025, making the buyback program perpetual. Previously, the program had a defined termination date, but now it may continue indefinitely subject to board discretion.
What execution mechanisms can the company use for future repurchases?: The company may conduct repurchases through negotiated transactions, open market purchases, Rule 10b-18 trading plans, Rule 10b5-1 plans, or accelerated stock repurchases. The specific mechanism used for H1 2026 repurchases was open-market purchases.
Why did the company not repurchase shares in Q2 2026?: The filing does not specify a reason for the absence of Q2 2026 repurchases. However, the company completed the $178.5 million acquisition of the Calabrian sulfur dioxide business on June 30, 2026, and increased term debt by $100 million, which may have influenced capital allocation priorities toward debt management and integration.
How does this buyback program fit into the company's overall capital strategy?: The company states it is 'focused on creating long-term stockholder value' and pursues 'synergistic acquisitions' alongside the buyback program. The perpetual authorization (as of October 2025) provides flexibility for opportunistic repurchases, though the company prioritizes maintaining adequate liquidity and debt ratios during periods of acquisition activity.

execution open-market rule-10b-18 industrial-manufacturing shareholder-return

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.